rs199973777
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP3BP4_ModerateBP6_Very_StrongBS2
The ENST00000449082.3(SCN10A):c.308G>A(p.Arg103Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,613,826 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R103W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000449082.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN10A | NM_006514.4 | c.308G>A | p.Arg103Gln | missense_variant | 3/28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN10A | ENST00000449082.3 | c.308G>A | p.Arg103Gln | missense_variant | 3/28 | 1 | NM_006514.4 | ENSP00000390600 | P4 | |
SCN10A | ENST00000655275.1 | c.308G>A | p.Arg103Gln | missense_variant | 3/28 | ENSP00000499510 | ||||
SCN10A | ENST00000643924.1 | c.308G>A | p.Arg103Gln | missense_variant | 2/27 | ENSP00000495595 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152122Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000283 AC: 71AN: 251020Hom.: 1 AF XY: 0.000302 AC XY: 41AN XY: 135640
GnomAD4 exome AF: 0.000146 AC: 213AN: 1461586Hom.: 1 Cov.: 31 AF XY: 0.000142 AC XY: 103AN XY: 727112
GnomAD4 genome AF: 0.000368 AC: 56AN: 152240Hom.: 1 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74446
ClinVar
Submissions by phenotype
Brugada syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 25, 2023 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at